BMO Capital analyst Evan Seigerman maintains Eli Lilly and Co (NYSE:LLY) with a Outperform and maintains $1001 price target.
BMO Capital Maintains Outperform on Eli Lilly and Co, Maintains $1001 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.